2022
DOI: 10.3389/fcell.2022.929256
|View full text |Cite
|
Sign up to set email alerts
|

Manipulating Cardiomyocyte Plasticity for Heart Regeneration

Abstract: Pathological heart injuries such as myocardial infarction induce adverse ventricular remodeling and progression to heart failure owing to widespread cardiomyocyte death. The adult mammalian heart is terminally differentiated unlike those of lower vertebrates. Therefore, the proliferative capacity of adult cardiomyocytes is limited and insufficient to restore an injured heart. Although current therapeutic approaches can delay progressive remodeling and heart failure, difficulties with the direct replenishment o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 162 publications
(192 reference statements)
0
1
0
Order By: Relevance
“…The direct conversion of cardiac fibroblasts into induced CMs represents an attractive strategy for cardiac repair and regeneration, with promising potential for clinical applications [96][97][98][99]. PTBP1 (polypyrimidine tract-binding protein 1), also known as hnRNP I, is one of the most characterized repressors of cardiac-specific alternative splicing events [100].…”
Section: Ptbp1 Regulates the Reprogramming Of Cardiac Fibroblasts Int...mentioning
confidence: 99%
“…The direct conversion of cardiac fibroblasts into induced CMs represents an attractive strategy for cardiac repair and regeneration, with promising potential for clinical applications [96][97][98][99]. PTBP1 (polypyrimidine tract-binding protein 1), also known as hnRNP I, is one of the most characterized repressors of cardiac-specific alternative splicing events [100].…”
Section: Ptbp1 Regulates the Reprogramming Of Cardiac Fibroblasts Int...mentioning
confidence: 99%
“…During the progression of HF, the heart gradually loses the ability to replace damaged tissues and regenerate [ 17 ]. Aiming at reactivating cardiomyocytes’ proliferation and restoring the lost myocardial tissue, regenerative medicine efforts for HF deeply differ from current therapeutic strategies that can only delay the ventricular remodeling process and simply postpone the occurrence of end-stage HF.…”
Section: Background/the State Of the Artmentioning
confidence: 99%